Dental Care Clinics in Corona, NY Accepting Medicare
29 Dental Care Clinics found. Showing 21 - 29
 Deepa Jayam, Dmd Pc Dentist Medicare: Not Enrolled in Medicare Practice Location: 3709 Junction Blvd, Corona, NY 11368 Phone: 516-884-1654 |
Corona Family Dental Center Dentist Medicare: Not Enrolled in Medicare Practice Location: 3766 Junction Boulevard, Corona, NY 11368 Phone: 718-898-1300 Fax: 718-533-8644 |
Sam Cosentino Dds Pc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 5212 108th St, Corona, NY 11368 Phone: 718-271-3100 Fax: 718-271-3100 |
Hanette Gomez Dds Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 9605 40th Rd, Corona, NY 11368 Phone: 718-651-7070 Fax: 718-651-6559 |
Roosevelt Orthodontics Dentist - Orthodontics and Dentofacial Orthopedics Medicare: Not Enrolled in Medicare Practice Location: 4003 National St, Corona, NY 11368 Phone: 718-458-9000 |
Ladino Dental Pllc Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 3756 103rd St Bsmt, Corona, NY 11368 Phone: 917-854-5645 |
Comfort Dental Spa Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 5121 108 St, Corona, NY 11368 Phone: 718-699-9500 Fax: 718-699-9021 |
L&l Dental Care, Llc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 100-17 Northern Blvd, 1a, Corona, NY 11369 Phone: 787-379-5952 |
Prohealth Dental Pllc Dentist Medicare: Not Enrolled in Medicare Practice Location: 3731 103rd St, Corona, NY 11368 Phone: 718-507-1500 |
News Archive
Helix BioPharma closes private placement of 4,530,000 units
Helix BioPharma Corp. today announced that it has closed a private placement of 4,530,000 units at $2.43 per unit.
Aliskiren drug can delay progression of congestive heart failure, lengthen survival rates
Researchers at the University of Arizona College of Medicine - Phoenix have shown for the first time in preclinical studies that Aliskiren, a drug that inhibits the enzyme that regulates blood pressure, can delay the progression of congestive heart failure and lengthen survival rates.
New treatment for sickle cell disease developed by Emmaus Medical receives positive opinion from EMA
Emmaus Medical, Inc., a pharmaceutical company developing a new treatment for sickle cell disease, and subsidiary of Emmaus Life Sciences, Inc., announced today that its investigational L-glutamine treatment for sickle cell disease has received a positive opinion recommending orphan medicinal product designation by the European Medicines Agency's (EMA) Committee for Orphan Medicinal Products (COMP). The designation allows Emmaus ten years of marketing exclusivity in EU member countries after the product obtains marketing authorization, as well as streamlined regulatory review processes and registration and other fee reductions.
Diet and weight may influence response to bipolar disorder treatment, shows study
Data from a clinical trial has shown that how people respond to treatment for Bipolar Disorder may be influenced by their weight and the overall quality of their diet, including whether they are eating a diet high in foods thought to contribute to general inflammation.
› Verified 2 days ago
- 1
- 2(current)